首页 > 最新文献

Uirusu最新文献

英文 中文
Pub Date : 2020-01-01 DOI: 10.2222/jsv.70.185
Akihisa Kato, Yasushi Kawaguchi
{"title":"","authors":"Akihisa Kato, Yasushi Kawaguchi","doi":"10.2222/jsv.70.185","DOIUrl":"https://doi.org/10.2222/jsv.70.185","url":null,"abstract":"","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"70 2","pages":"185-190"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39433997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[African swine fever]. [非洲猪瘟]。
Pub Date : 2020-01-01 DOI: 10.2222/jsv.70.15
Takehiro Kokuho

African swine fever (ASF) is a hemorrhagic infectious disease of Suids, which is endemic in sub-Saharan area of African continent. ASF is usually circulating sub-symptomatically among wild species of Suidae family, such as warthogs and bush pigs, by mediating Ornithodoros soft ticks. Domestic pigs (Sus scrofa) are, however, highly sensitive to the infection and show severe clinical signs with a high mortality rate, resulting a huge impact on pork production. Currently, there is no treatment or vaccine available. The etiological agent, ASFV, is highly resistant to environmental conditions, and resides in unheated pork meat or pork meat products for a long period, which may be a chance of its long-distance spread. Since August 2018, ASFV has been circulating in East and Southeast Asian countries and may possibly be introduced into Japan. Here, I describe the outline of the disease and the etiology of the pathogen in order to remind the importance of "awareness" and "preparedness" for the disease.

非洲猪瘟(ASF)是一种猪的出血性传染病,流行于非洲大陆撒哈拉以南地区。非洲猪瘟通常通过鸟thodoros软蜱媒介在猪科野生种(如疣猪和丛林猪)中以亚症状传播。然而,家猪(Sus scrofa)对感染高度敏感,表现出严重的临床症状,死亡率高,对猪肉生产造成巨大影响。目前,没有治疗方法或疫苗可用。非洲猪瘟病毒对环境条件具有很强的抵抗力,可长期驻留在未加热的猪肉或猪肉制品中,这可能是其远距离传播的机会。自2018年8月以来,非洲猪瘟一直在东亚和东南亚国家传播,并有可能传入日本。在这里,我描述了疾病的概况和病原体的病原学,以提醒人们对疾病的“认识”和“准备”的重要性。
{"title":"[African swine fever].","authors":"Takehiro Kokuho","doi":"10.2222/jsv.70.15","DOIUrl":"https://doi.org/10.2222/jsv.70.15","url":null,"abstract":"<p><p>African swine fever (ASF) is a hemorrhagic infectious disease of Suids, which is endemic in sub-Saharan area of African continent. ASF is usually circulating sub-symptomatically among wild species of Suidae family, such as warthogs and bush pigs, by mediating Ornithodoros soft ticks. Domestic pigs (Sus scrofa) are, however, highly sensitive to the infection and show severe clinical signs with a high mortality rate, resulting a huge impact on pork production. Currently, there is no treatment or vaccine available. The etiological agent, ASFV, is highly resistant to environmental conditions, and resides in unheated pork meat or pork meat products for a long period, which may be a chance of its long-distance spread. Since August 2018, ASFV has been circulating in East and Southeast Asian countries and may possibly be introduced into Japan. Here, I describe the outline of the disease and the etiology of the pathogen in order to remind the importance of \"awareness\" and \"preparedness\" for the disease.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"70 1","pages":"15-28"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38964407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[COVID-19: From a clinician's perspective.] [COVID-19:从临床医生的角度]
Pub Date : 2020-01-01 DOI: 10.2222/jsv.70.37
Satoshi Kutsuna

Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by SARS-CoV-2. As of March 30, 2020, there have been 693,224 reported patients with COVID-19 worldwide, with 1,446 in Japan. Currently, although aspects of the route of transmission are unclear, infection by contact and by inhaling droplets is considered to be the dominant transmission route. Inflammatory symptoms in the upper respiratory tract persist for several days to 1 week after onset, and in some patients symptoms of pneumonia worsen and become severe. The presence of underlying diseases and advanced age are risk factors for increased severity. Diagnosis is based on detection of SARS-CoV-2 by polymerase chain reaction (PCR) testing of nasopharyngeal swabs or sputum. Symptomatic management is the main treatment for this disease. Although the efficacy of several agents is currently being tested, at present there is no effective therapeutic agent. To prevent infection, in addition to standard preventive measures, measures that counteract infection by contact and droplet inhalation are important. In addition, if procedures that cause aerosolization of virus are used, then measures that prevent airborne infection should be implemented.

冠状病毒病2019 (COVID-19)是由SARS-CoV-2引起的呼吸道感染。截至2020年3月30日,全球共报告了693224例COVID-19患者,其中日本有1446例。目前,虽然传播途径的各个方面尚不清楚,但接触感染和吸入飞沫感染被认为是主要的传播途径。发病后上呼吸道炎症症状持续数天至1周,部分患者肺炎症状加重。存在潜在疾病和高龄是严重程度增加的危险因素。诊断是基于对鼻咽拭子或痰液进行聚合酶链反应(PCR)检测检测SARS-CoV-2。对症治疗是本病的主要治疗方法。虽然目前正在测试几种药物的疗效,但目前还没有有效的治疗药物。为了预防感染,除了标准的预防措施外,通过接触和吸入飞沫抵消感染的措施也很重要。此外,如果使用了导致病毒雾化的程序,则应实施防止空气传播感染的措施。
{"title":"[COVID-19: From a clinician's perspective.]","authors":"Satoshi Kutsuna","doi":"10.2222/jsv.70.37","DOIUrl":"https://doi.org/10.2222/jsv.70.37","url":null,"abstract":"<p><p>Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by SARS-CoV-2. As of March 30, 2020, there have been 693,224 reported patients with COVID-19 worldwide, with 1,446 in Japan. Currently, although aspects of the route of transmission are unclear, infection by contact and by inhaling droplets is considered to be the dominant transmission route. Inflammatory symptoms in the upper respiratory tract persist for several days to 1 week after onset, and in some patients symptoms of pneumonia worsen and become severe. The presence of underlying diseases and advanced age are risk factors for increased severity. Diagnosis is based on detection of SARS-CoV-2 by polymerase chain reaction (PCR) testing of nasopharyngeal swabs or sputum. Symptomatic management is the main treatment for this disease. Although the efficacy of several agents is currently being tested, at present there is no effective therapeutic agent. To prevent infection, in addition to standard preventive measures, measures that counteract infection by contact and droplet inhalation are important. In addition, if procedures that cause aerosolization of virus are used, then measures that prevent airborne infection should be implemented.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"70 1","pages":"37-44"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38883715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pathology and Immunology of COVID-19]. 【新冠肺炎病理与免疫学】。
Pub Date : 2020-01-01 DOI: 10.2222/jsv.70.167
Shun Iida, Tadaki Suzuki

Since the first case of COVID-19 was reported from Wuhan, China in December 2019, SARS-CoV-2 has been spreading globally and has become major public health concern. At present, development of specific treatment for COVID-19 is in progress and several countermeasures have been subjected to clinical trials. However, efficacy of these countermeasures is limited. For development of effective medicines or vaccines against infectious diseases, it is mandatory to elucidate its etiology and pathogenesis by means of pathological analysis. Pathological studies revealed that the COVID-19 mainly affects respiratory tracts although other organs are also involved. In addition, immunological studies demonstrated that host immune response may exacerbates COVID-19 through systemic inflammation. In this review, we would like to overview pathology and immunology of COVID-19.

自2019年12月中国武汉报告首例COVID-19病例以来,SARS-CoV-2已在全球蔓延,成为重大公共卫生问题。目前,针对COVID-19的特异性治疗正在开发中,几种对策已进入临床试验阶段。然而,这些对策的效力是有限的。为了开发有效的传染病药物或疫苗,必须通过病理分析来阐明其病因和发病机制。病理研究表明,新冠肺炎主要影响呼吸道,但也涉及其他器官。此外,免疫学研究表明,宿主免疫反应可能通过全身炎症加剧COVID-19。在这篇综述中,我们就COVID-19的病理和免疫学进行综述。
{"title":"[Pathology and Immunology of COVID-19].","authors":"Shun Iida,&nbsp;Tadaki Suzuki","doi":"10.2222/jsv.70.167","DOIUrl":"https://doi.org/10.2222/jsv.70.167","url":null,"abstract":"<p><p>Since the first case of COVID-19 was reported from Wuhan, China in December 2019, SARS-CoV-2 has been spreading globally and has become major public health concern. At present, development of specific treatment for COVID-19 is in progress and several countermeasures have been subjected to clinical trials. However, efficacy of these countermeasures is limited. For development of effective medicines or vaccines against infectious diseases, it is mandatory to elucidate its etiology and pathogenesis by means of pathological analysis. Pathological studies revealed that the COVID-19 mainly affects respiratory tracts although other organs are also involved. In addition, immunological studies demonstrated that host immune response may exacerbates COVID-19 through systemic inflammation. In this review, we would like to overview pathology and immunology of COVID-19.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"70 2","pages":"167-174"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39433995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Development of hepatitis B virus culture systems]. 乙肝病毒培养系统的发展
Pub Date : 2020-01-01 DOI: 10.2222/jsv.70.135
Yuichi Akahori, Makoto Hijikata

Recent development of hepatitis B virus (HBV) culture systems has proceeded the molecular virological studies of the life cycle of HBV including infection step. However, the reproduction of HBV life cycle under the more physiological condition may be required to know the nature of HBV more precisely. The HBV culture system, we recently developed using immortalized human hepatocytes cultured in the three dimensional condition, seemed to be one of good tools for that purpose.

近年来,乙型肝炎病毒(HBV)培养系统的发展已经开始了包括感染步骤在内的HBV生命周期的分子病毒学研究。然而,可能需要更生理条件下HBV生命周期的再现,才能更准确地了解HBV的性质。我们最近开发的HBV培养系统,使用在三维条件下培养的永生化人肝细胞,似乎是实现这一目的的好工具之一。
{"title":"[Development of hepatitis B virus culture systems].","authors":"Yuichi Akahori,&nbsp;Makoto Hijikata","doi":"10.2222/jsv.70.135","DOIUrl":"https://doi.org/10.2222/jsv.70.135","url":null,"abstract":"<p><p>Recent development of hepatitis B virus (HBV) culture systems has proceeded the molecular virological studies of the life cycle of HBV including infection step. However, the reproduction of HBV life cycle under the more physiological condition may be required to know the nature of HBV more precisely. The HBV culture system, we recently developed using immortalized human hepatocytes cultured in the three dimensional condition, seemed to be one of good tools for that purpose.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"70 2","pages":"135-146"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39433992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Structural studies on negative-strand RNA virus]. 负链RNA病毒的结构研究。
Pub Date : 2020-01-01 DOI: 10.2222/jsv.70.91
Yukihiko Sugita

Negative-strand RNA viruses do not possess a rigid viral shell, and their structures are flexible and fragile. We have applied various electron microscopies to analyze the morphologies of influenza and Ebola virus. Our studies have revealed the native interior and exterior ultrastructures of influenza virus as well as the assembly of Ebola virus core in atomic detail.

负链RNA病毒没有刚性的病毒外壳,它们的结构是灵活而脆弱的。我们已经应用了各种电子显微镜来分析流感和埃博拉病毒的形态。我们的研究揭示了流感病毒的内部和外部超微结构以及埃博拉病毒核心的原子细节组装。
{"title":"[Structural studies on negative-strand RNA virus].","authors":"Yukihiko Sugita","doi":"10.2222/jsv.70.91","DOIUrl":"https://doi.org/10.2222/jsv.70.91","url":null,"abstract":"<p><p>Negative-strand RNA viruses do not possess a rigid viral shell, and their structures are flexible and fragile. We have applied various electron microscopies to analyze the morphologies of influenza and Ebola virus. Our studies have revealed the native interior and exterior ultrastructures of influenza virus as well as the assembly of Ebola virus core in atomic detail.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"70 1","pages":"91-100"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38883721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Molecular mechanisms of highly pathogenic viruses' replication and their applications for a novel drug discovery]. [高致病性病毒复制的分子机制及其在新药开发中的应用]。
Pub Date : 2020-01-01 DOI: 10.2222/jsv.70.69
Shuzo Urata

Productive (lytic) replication of DNA viruses elicits host cell DNA damage responses, which cause both beneficial and detrimental effects on viral replication. Viruses utilize them and selectively cancel the 'noisy' downstream signaling pathways, leading to maintain high S-phase CDK activities required for viral replication. To achieve this fine tuning of cellular environment, herpesviruses encode many (>70) genes in their genome, which are expressed in a strictly regulated temporal cascade (immediate-early, early, and late). Here, I introduce and discuss how Epstein-Barr virus, an oncogenic herpesvirus, hijacks the cellular environment and adapt it for the progeny production.

DNA病毒的高产(裂解)复制引起宿主细胞DNA损伤反应,这对病毒复制产生有益和有害的影响。病毒利用它们并选择性地取消“嘈杂的”下游信号通路,从而维持病毒复制所需的高s期CDK活性。为了实现细胞环境的这种微调,疱疹病毒在其基因组中编码了许多(>70)个基因,这些基因在严格调控的时间级联(即早、早、晚)中表达。在这里,我介绍和讨论爱泼斯坦-巴尔病毒,一种致癌疱疹病毒,如何劫持细胞环境并使其适应后代的生产。
{"title":"[Molecular mechanisms of highly pathogenic viruses' replication and their applications for a novel drug discovery].","authors":"Shuzo Urata","doi":"10.2222/jsv.70.69","DOIUrl":"https://doi.org/10.2222/jsv.70.69","url":null,"abstract":"<p><p>Productive (lytic) replication of DNA viruses elicits host cell DNA damage responses, which cause both beneficial and detrimental effects on viral replication. Viruses utilize them and selectively cancel the 'noisy' downstream signaling pathways, leading to maintain high S-phase CDK activities required for viral replication. To achieve this fine tuning of cellular environment, herpesviruses encode many (>70) genes in their genome, which are expressed in a strictly regulated temporal cascade (immediate-early, early, and late). Here, I introduce and discuss how Epstein-Barr virus, an oncogenic herpesvirus, hijacks the cellular environment and adapt it for the progeny production.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"70 1","pages":"69-82"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38883718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Basis of coronavirus infection, and SARS-CoV-2]. [冠状病毒感染和SARS-CoV-2的基础]。
Pub Date : 2020-01-01 DOI: 10.2222/jsv.70.155
Kazuya Shirato
At the end of December 2019, novel pneumonia emerged in Wuhan city, China, and it caused by novel coronavirus. Causative virus designated as Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), and the diseases name was Coronavirus Disease 2019 (COVID-19). At first, SARS-CoV-2 was regarded as kind of SARS-CoV and Middle East Respiratory Syndrome coronavirus (MERS-CoV). However, it was misunderstanding and SARS-CoV-2 was similar to human coronaviruses. Here, to help better understanding for SARS-CoV-2, the basis of coronavirus infection was described.
{"title":"[Basis of coronavirus infection, and SARS-CoV-2].","authors":"Kazuya Shirato","doi":"10.2222/jsv.70.155","DOIUrl":"https://doi.org/10.2222/jsv.70.155","url":null,"abstract":"At the end of December 2019, novel pneumonia emerged in Wuhan city, China, and it caused by novel coronavirus. Causative virus designated as Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), and the diseases name was Coronavirus Disease 2019 (COVID-19). At first, SARS-CoV-2 was regarded as kind of SARS-CoV and Middle East Respiratory Syndrome coronavirus (MERS-CoV). However, it was misunderstanding and SARS-CoV-2 was similar to human coronaviruses. Here, to help better understanding for SARS-CoV-2, the basis of coronavirus infection was described.","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"70 2","pages":"155-166"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39433994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Review Norovirus]. (审查诺瓦克病毒)。
Pub Date : 2020-01-01 DOI: 10.2222/jsv.70.117
Kazuhiko Katayama

Noroviruses commonly cause infectious gastroenteritis and massive food poisoning. There is an urgent need to elucidate the infection mechanism of noroviruses and to develop vaccines and therapeutic drugs. In addition to human disease, noroviruses have been implicated in animal disease. Noroviruses that cause murine diseases can be propagated in strained cultured cells, and for many years, murine norovirus has been used as a model for human noroviruses that could not be propagated in cultured cells. That model and advances in technology have been instrumental in basic studies of noroviruses. From structural biology, noroviruses undergo dynamic shape changes to improve their infectivity when they infect cells. New culture techniques have made human intestinal organoids available for studying the mechanisms of pathogenic expression of human noroviruses in the intestinal tract, mechanisms of infection growth, and the search for receptor molecules. Vaccines and antivirals using human intestinal organoids are under active development, and some are already in clinical trials. In this paper, I review the latest research results, vaccine development, and other advances from the history of norovirus discovery.

诺如病毒通常引起感染性胃肠炎和大量食物中毒。迫切需要阐明诺如病毒的感染机制,开发疫苗和治疗药物。除人类疾病外,诺如病毒还与动物疾病有关。引起小鼠疾病的诺如病毒可以在培养细胞中繁殖,多年来,小鼠诺如病毒一直被用作不能在培养细胞中繁殖的人类诺如病毒的模型。该模型和技术进步有助于诺如病毒的基础研究。从结构生物学来看,诺如病毒在感染细胞时经历动态形状变化以提高其传染性。新的培养技术使人类肠道类器官可用于研究人类诺如病毒在肠道中的致病表达机制、感染生长机制和寻找受体分子。利用人类肠道类器官的疫苗和抗病毒药物正在积极开发中,有些已经进入临床试验阶段。在本文中,我回顾了诺如病毒发现史上的最新研究成果、疫苗开发和其他进展。
{"title":"[Review Norovirus].","authors":"Kazuhiko Katayama","doi":"10.2222/jsv.70.117","DOIUrl":"https://doi.org/10.2222/jsv.70.117","url":null,"abstract":"<p><p>Noroviruses commonly cause infectious gastroenteritis and massive food poisoning. There is an urgent need to elucidate the infection mechanism of noroviruses and to develop vaccines and therapeutic drugs. In addition to human disease, noroviruses have been implicated in animal disease. Noroviruses that cause murine diseases can be propagated in strained cultured cells, and for many years, murine norovirus has been used as a model for human noroviruses that could not be propagated in cultured cells. That model and advances in technology have been instrumental in basic studies of noroviruses. From structural biology, noroviruses undergo dynamic shape changes to improve their infectivity when they infect cells. New culture techniques have made human intestinal organoids available for studying the mechanisms of pathogenic expression of human noroviruses in the intestinal tract, mechanisms of infection growth, and the search for receptor molecules. Vaccines and antivirals using human intestinal organoids are under active development, and some are already in clinical trials. In this paper, I review the latest research results, vaccine development, and other advances from the history of norovirus discovery.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"70 2","pages":"117-128"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39433988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The role of HTLV-1 provirus in clonal selection of the infected cells]. HTLV-1原病毒在感染细胞克隆选择中的作用
Pub Date : 2019-01-01 DOI: 10.2222/jsv.69.23
Misaki Matsuo, Paola Miyazato, Yorifumi Satou

HTLV-1 inserts its viral genome into the host cellular DNA in the form of a provirus. The proviral DNA is a key to understand the persistence and pathogenesis of HTLV-1 infection. There has been a significant progress in proviral research due to technological advances on DNA sequencing.Next generation sequencing technology revolutionized our understanding of the human genome,showing how it is organized and regulated, not only by the nucleotide sequence itself but also by epigenetic features and higher-order chromatin structure. We will review recent findings regarding the role of HTLV-1 provirus in HTLV-1 infection.

HTLV-1以原病毒的形式将其病毒基因组插入宿主细胞DNA中。前病毒DNA是了解HTLV-1感染持久性和发病机制的关键。由于DNA测序技术的进步,原病毒的研究取得了重大进展。下一代测序技术彻底改变了我们对人类基因组的理解,不仅通过核苷酸序列本身,而且通过表观遗传特征和高阶染色质结构,展示了它是如何组织和调节的。我们将回顾关于HTLV-1病毒在HTLV-1感染中的作用的最新发现。
{"title":"[The role of HTLV-1 provirus in clonal selection of the infected cells].","authors":"Misaki Matsuo,&nbsp;Paola Miyazato,&nbsp;Yorifumi Satou","doi":"10.2222/jsv.69.23","DOIUrl":"https://doi.org/10.2222/jsv.69.23","url":null,"abstract":"<p><p>HTLV-1 inserts its viral genome into the host cellular DNA in the form of a provirus. The proviral DNA is a key to understand the persistence and pathogenesis of HTLV-1 infection. There has been a significant progress in proviral research due to technological advances on DNA sequencing.Next generation sequencing technology revolutionized our understanding of the human genome,showing how it is organized and regulated, not only by the nucleotide sequence itself but also by epigenetic features and higher-order chromatin structure. We will review recent findings regarding the role of HTLV-1 provirus in HTLV-1 infection.</p>","PeriodicalId":75275,"journal":{"name":"Uirusu","volume":"69 1","pages":"23-28"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38388236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Uirusu
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1